AbCellera Announces Collaboration with Incyte to Accelerate the Discovery and Development of Therapeutic Antibodies in Oncology Read more
Takeda Announces FDA Acceptance of BLA for Subcutaneous Administration of ENTYVIO (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease Read more
Dewpoint Therapeutics Partners with Chemify to Apply Groundbreaking Chemistry AI to Radically Accelerate the Discovery of Molecules Targeting Cancer and Neurodegeneration Read more
Sandoz announces exclusive deal to commercialize biosimilar ustekinumab, further reinforcing growing pipeline and immunology patient offering Read more
Biocytogen Enters into Antibody Evaluation, Option and License Agreement with Myricx for ADC Development Read more
Broad Institute of MIT and Harvard announces a new research alliance with Novo Nordisk to identify therapeutic targets for type 2 diabetes and cardiometabolic diseases Read more